Kenalog is a prescription only medicine which contains the active ingredient Triamcinolone Acetonide. Kenalog is administered via intra-articular/intramuscular injection and is used to treat various allergic disorders including asthma, blood disorders, hormone problems, rheumatic fever, and problems associated with the digestive system. Kenalog is also used for the treatment of joint pain, swelling and stiffness in inflammatory disorders such as rheumatoid arthritis.
Practitioners please note:
- In line with our clinical governance process and in the interests of patient safety, we supply Kenalog only to those practitioners who are registered healthcare professionals.
Prescribers please note:
- Prescribing unlicensed medicines or medicines which are being used outside the recommendations of their marketing authorisation (off-label) alters the prescriber’s professional responsibility and potential liability.
- The prescriber should be able to justify and feel competent in using such medicines, and also inform the patient that the prescribed medicine is being used off-label or is unlicensed.
Mode of action:
Triamcinolone acetonide is a synthetic glucocorticoid with marked anti-inflammatory and anti-allergic actions.
Contraindications:
- Hypersensitivity to any of the ingredients.
- Systemic infections unless specific anti-infective therapy is employed.
- Administration by intravenous, intrathecal, epidural, or intraocular injection.
Warning:
Cases of serious anaphylactic reactions and anaphylactic shock, including death, have been reported in individuals receiving triamcinolone acetonide injection, regardless of the route of administration.
EMC: https://www.medicines.org.uk/emc/product/6748
Patient Information Leaflet:https://www.medicines.org.uk/emc/files/pil.6748.pdf
